Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification.

Xiaoxiao HuYilu ZhouCharlotte HillKai ChenCheng ChengXiaowei LiuPeiwen DuanYaoyao GuYeming WuRob M EwingZhongrong LiZhixiang Wu Yihua Wang

Published in: British journal of cancer (2024)

We propose that transcriptional subtyping may enhance precision prognosis and therapy stratification for patients with MYCN non-amplified neuroblastomas.

Keyphrases

gene expression
dna methylation
single molecule
cell therapy
replacement therapy